{"name":"Ritter Pharmaceuticals, Inc.","slug":"ritter-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"RP-G28","genericName":"RP-G28","slug":"rp-g28","indication":"Hyperammonemia in urea cycle disorder patients","status":"phase_3"}]}],"pipeline":[{"name":"RP-G28","genericName":"RP-G28","slug":"rp-g28","phase":"phase_3","mechanism":"RP-G28 is a non-systemic oral therapeutic that modulates the gut microbiome to improve metabolic and immune function.","indications":["Hyperammonemia in urea cycle disorder patients"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAJBVV95cUxPc01xd3kxRXlnVVRyeEJSWHhvdmo3Sy1MWWxXZ1R3dmFVc2V1WG1KUHBGWk41QWFzalc3R2NfNTd6X0NnZDdrcDlISlJrWWtzU3RfdmRUSGdES093cVdqZzUxeVY5aTdET0JJM2xoanBNVzl6QzAxZ3Btaldab2NnbjJmSmxPMGlRdUlqUFBxN3BuS2NfZ2VzMThzbm9icDdZSVFRZkRwTklZbG54WXZUWmVodVExVkRlcUpDOVhNMjRHYmwyUzIzaDdTS2E5UG9Sa0VHeVZ4MEVITUtqU2g5ZzlJRUpyOVZYTjJSOWRvVHY0aUh1WDRabzRNOVd1Z0o0Nm9nQk1ZTXBsM1c1V3ZzZ2lvNmtvamdOeWxaeFZwQXFQY0R2d0tyVjhKYkUxZHk4YkgwejdhUkVFZnN0RDBxQ1NOVDQyY0VU?oc=5","date":"2024-09-30","type":"pipeline","source":"GlobeNewswire","summary":"Microbiome Therapeutics Market Forecast at $21.5 Billion by - GlobeNewswire","headline":"Microbiome Therapeutics Market Forecast at $21.5 Billion by","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5kdlFqR05Ed0NJdk1rRnlYRzZPdmV6ZTlqenBTQVhwbGtwbGk1VkxBb3VIbkFmNzJRbE5EZ2U3cV9sTTFnU2ZTTTF0Yk13dVpFYVNIbVVwd3k2bm5yZ0c0QzY1WXB6Z1ZZMkVWQQ?oc=5","date":"2022-01-12","type":"pipeline","source":"Pharma Voice","summary":"Talent Pool - Pharma Voice","headline":"Talent Pool","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQeEtSbmlrQjdXdlhucDFpOVd6N1JIVFNrZUk0Z0ljdTctN0hZZXJMRXR5UnQ4TjZCeXpiV3FfbjU0Qm51Y3BkbmtDNjNNUWU5VWdUSEU3WXlERXVhME9lQlp0TGFJc0p1RTRlRDdJZjZ5bWs0M1hFQ0VlZlJOWlY2R1dLbVlpZTJsZEpxdmhEREdWODBlcjBUWDAtVkIwSDFzVVdZc2NGTVJoRldHTTVfOQ?oc=5","date":"2021-05-24","type":"pipeline","source":"MedCity News","summary":"Docbot CEO highlights how AI can be applied to gastrointestinal image analysis - MedCity News","headline":"Docbot CEO highlights how AI can be applied to gastrointestinal image analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNNTJMUDdvZnAzSGVnTU1hT09KOWN4ei00TEpxNUh2Rnd4WjllVHdrandlRUpxUTdiNk1uM3QwMHVicnJBWF93NzZNbEctcGIwUURZZEtxSHZsX0VUbnM3MUZMQVdkOHV5R0FCcExOM2gtVDVPZzRlWXFUOWMtTGhyQkhqNEZsYWlBdDFlcENSSjA3X3hiUXc3cDBkVjVMRjRJbUl0VlJBZWhoWjVSdzFUMWtUcVNZZE9IX29UYVk3OXphcU5JU1loeGYxS3RKbnhfSG41b0p1MXNlaXFWWm1kZXZyaTB4MTJvb1BUdk5ZTDN3M19SOGptSQ?oc=5","date":"2020-05-22","type":"deal","source":"GlobeNewswire","summary":"Ritter Pharmaceuticals, Inc. Announces Expected Closing of Merger Transaction with Qualigen, Inc. - GlobeNewswire","headline":"Ritter Pharmaceuticals, Inc. Announces Expected Closing of Merger Transaction with Qualigen, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNRURkQXRncW1mNDNoQXBKN1AxWk9PMXUxV3F5cDNMaG4yWDk0a0RyY0xLeEVYT1F1azRmT2Q0LXpQZ1pfVV9BdXRoQ1JVS2x1QWc4SmJnUVZWZ3RmUXV3OUdJSDRRUHhuYi1zQlgxa3dFamxnVDdTS0NKWVAtT0VKZ1lMaDhNS2ZqYmlMNDlR?oc=5","date":"2020-01-22","type":"deal","source":"labusinessjournal.com","summary":"Ritter Pharmaceuticals to Be Acquired by Qualigen - labusinessjournal.com","headline":"Ritter Pharmaceuticals to Be Acquired by Qualigen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQa0RnSG5BQm1xbk5OQW9aUXJpdEFnZWwwOE4wOWd1RHByUGdXNmN0YVU2UEl0bFEyWDBkck44OEtQcGRGVHR2dlBhX1VFamxtWVp1RFVsbmV2aUhjNVpQZzk1Tmx6VUNGeTlUdDVRdFJnb3JKZTFXM1JUeThhYjJhaE5TT0gwaXVHcVJEOWFzNnM4UUZlaVNlQUszRDlhNV92Nk5B?oc=5","date":"2019-09-13","type":"trial","source":"Fierce Biotech","summary":"Ritter's microbiome modulator fails lactose intolerance phase 3 - Fierce Biotech","headline":"Ritter's microbiome modulator fails lactose intolerance phase 3","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE11eHNWUm92RTg5ZG5FQWtPdkVYSVN2eksyZlFteVlPNXFvSC0zanJPTk11YVhraVVTd3VEdl83R1paSkE0aUFIS3FZUFZsTzBSZUE?oc=5","date":"2018-07-06","type":"pipeline","source":"Nature","summary":"People - Nature","headline":"People","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNcDVJcjlHOXNBRk9mMWRTR0dlcEdnNE1xb25ubTljNm1tamwtc2dOdEg5czFDRkVaTS02Q1Yyc2s1Q3NuVFF0Qzg5bUJ2VGZwX0VDODFJWENHRS1KUklVTTFRYUhaRmZkXzJLSUFtT0tFUWZkRnFWaXp2NGFLajZnTmp4MA?oc=5","date":"2016-12-04","type":"pipeline","source":"Los Angeles Times","summary":"From teenage science project to Nasdaq - Los Angeles Times","headline":"From teenage science project to Nasdaq","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE12bU4yUjBBbWhfWmlhZnVUZ082NE1oM2wwWXBodFB2OVVGLThNUlg2YXJHeWtqOHJ6Z19VbUtjOEttVHFpQ3ZtWVBOdlUtbUg5OUJwY2FSLXlGZw?oc=5","date":"2016-08-17","type":"pipeline","source":"MarketBeat","summary":"Ritter Pharmaceuticals (RTTR) Stock Price, News & Analysis $RTTR - MarketBeat","headline":"Ritter Pharmaceuticals (RTTR) Stock Price, News & Analysis $RTTR","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}